Mirum Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:MIRM Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
27 Mar 24	BuyUS$49,600	Eric Bjerkholt	Individual	2,000	US$24.80
25 Mar 24	SellUS$111,017	Peter Radovich	Individual	4,303	US$25.80
18 Mar 24	BuyUS$51,600	Eric Bjerkholt	Individual	2,000	US$25.80
02 Feb 24	SellUS$157,491	Christopher Peetz	Individual	6,013	US$26.19
02 Feb 24	SellUS$31,797	Pamela Vig	Individual	1,214	US$26.19
02 Feb 24	SellUS$46,883	Peter Radovich	Individual	1,790	US$26.19
02 Feb 24	SellUS$22,184	Lara Longpre	Individual	847	US$26.19
08 Jan 24	SellUS$146,033	Christopher Peetz	Individual	5,209	US$28.03
08 Jan 24	SellUS$39,472	Pamela Vig	Individual	1,408	US$28.03
08 Jan 24	SellUS$39,473	Peter Radovich	Individual	1,408	US$28.03
08 Jan 24	SellUS$28,568	Lara Longpre	Individual	1,019	US$28.04
13 Sep 23	BuyUS$81,425	Frazier Life Sciences Management, LP	Company	2,625	US$31.02
12 Sep 23	BuyUS$256,791	Frazier Life Sciences Management, LP	Company	8,437	US$30.60
11 Sep 23	BuyUS$296,492	Eric Bjerkholt	Individual	10,000	US$29.65
31 Aug 23	BuyUS$43,713,358	Frazier Life Sciences Management, LP	Company	1,667,294	US$26.25
31 Aug 23	BuyUS$3,884,764	Frazier Life Sciences Management, LP	Company	147,991	US$26.25
25 Aug 23	SellUS$90,743	Jolanda Howe	Individual	3,459	US$26.23
03 Jul 23	SellUS$141,005	Christopher Peetz	Individual	5,498	US$25.65
03 Jul 23	SellUS$25,749	Lara Longpre	Individual	1,004	US$25.65
03 Jul 23	SellUS$36,546	Peter Radovich	Individual	1,425	US$25.65
03 Jul 23	SellUS$36,546	Pamela Vig	Individual	1,425	US$25.65

Insider Trading Volume

Insider Buying: MIRM insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of MIRM?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	4,235	0.00802%
State or Government	39,154	0.0742%
Individual Insiders	902,500	1.71%
Hedge Funds	4,370,024	8.28%
VC/PE Firms	6,495,392	12.3%
Institutions	40,973,862	77.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.9%.

Top Shareholders

Top 25 shareholders own 85.61% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.8%	Frazier Life Sciences Management, LP	6,495,392	US$156.0m	0.39%	7.2%
9.3%	BVF Partners L.P.	4,370,024	US$104.9m	0%	2.57%
5.67%	Eventide Asset Management, LLC	2,663,649	US$64.0m	-32.7%	1.08%
5.27%	The Vanguard Group, Inc.	2,476,244	US$59.5m	46.2%	no data
5.24%	BlackRock, Inc.	2,461,750	US$59.1m	16.5%	no data
4.39%	Janus Henderson Group plc	2,062,551	US$49.5m	7.21%	0.02%
4.12%	Cadian Capital Management, LP	1,934,922	US$46.5m	34.9%	1.88%
3.94%	Rock Springs Capital Management LP	1,851,464	US$44.5m	1.69%	1.26%
3.69%	State Street Global Advisors, Inc.	1,734,775	US$41.7m	7.02%	no data
3.19%	Novo Holdings A/S	1,500,000	US$36.0m	0%	0.02%
3.07%	Citadel Advisors LLC	1,442,812	US$34.6m	-16%	0.04%
2.48%	T. Rowe Price Group, Inc.	1,164,682	US$28.0m	3,540%	no data
2.43%	Avidity Partners Management, L.P.	1,142,850	US$27.4m	0%	1.06%
2.42%	Tang Capital Management, LLC	1,137,107	US$27.3m	0%	2.95%
1.94%	Franklin Resources, Inc.	912,575	US$21.9m	22.6%	0.01%
1.91%	Medical Strategy GmbH, Asset Management Arm	898,782	US$21.6m	0%	1.31%
1.78%	First Turn Management, LLC	836,302	US$20.1m	0%	3.33%
1.69%	Pictet Asset Management Limited	793,655	US$19.1m	7.39%	0.01%
1.55%	Norges Bank Investment Management	727,684	US$17.5m	0%	no data
1.45%	Geode Capital Management, LLC	681,180	US$16.4m	18.5%	no data
1.33%	Polar Capital Holdings Plc	625,000	US$15.0m	-46.8%	0.06%
1.32%	William Blair Investment Management, LLC	621,778	US$14.9m	16.5%	0.02%
1.26%	AXA Investment Managers S.A.	593,713	US$14.3m	-3.79%	0.03%
1.22%	Adage Capital Management, L.P.	575,000	US$13.8m	-13.5%	0.03%
1.14%	Perceptive Advisors LLC	534,942	US$12.8m	-20.4%	0.3%